2026-01-15 - Analysis Report
**1. Company Overview**
Ventas Inc is a real estate investment trust (REIT) that owns and operates healthcare and senior living facilities.

**2. Return Analysis**
- **Review Stock (VTR)**: 106.94%
- **Comparison Stock (VOO)**: 92.89%
- **Divergence (max: 35.10, min: -54.70, current: 14.10, relative divergence: 76.60%)**


**3. Alpha, Beta, and Capital Analysis**
| Period     | CAGR  | MDD   | Alpha | Beta | Cap(B) |
|------------|-------|-------|-------|-------|---------|
| 2016-2018  | 5.0%  | 17.1% | 2.0%  | 0.4   | 27.5B   |
| 2017-2019  | -10.0%| 22.6% | -27.0%| 0.2   | 27.1B   |
| 2018-2020  | 39.0% | 40.3% | 18.0% | 1.3   | 23.0B   |
| 2019-2021  | 10.0% | 40.3% | -33.0%| 1.4   | 24.0B   |
| 2020-2022  | 18.0% | 36.3% | 20.0% | 1.3   | 21.2B   |
| 2021-2023  | 18.0% | 33.8% | 17.0% | 0.8   | 23.4B   |
| 2022-2024  | 41.0% | 33.8% | 22.0% | 0.7   | 27.7B   |
| 2023-2025  | 88.0% | 15.2% | 26.0% | 0.5   | 36.4B   |


**4. Stock Price Fluctuation**
- **5-day SMA**: $75.90
- **20-day SMA**: $77.73
- **60-day SMA**: $76.95

**5. Recent Stock Price**
- **Last Market**: $76.92

**6. RSI, PPO, and Delta Analysis**
- **RSI**: 34.94
- **PPO**: -0.28

**7. Financial Analysis**
- The company's **Expected Return (%)** is -4.00%.
- **Risk Level: Medium** (MRI 0.70)


**8. News and Significant Events**
- Recent news articles include boosts in stock position, quarterly earnings previews, and other financial updates.


**9. Analyst Opinions**
- **Analyst Consensus:** Buy
- **Mean (1=StrongBuy~5=Sell):** 1.52 (~Buy)
- **Opinions:** 20
- **Target Price (avg/high/low):** 85.65 / 94.00 / 75.00


**10. Earnings Analysis**
| Date     | EPS | Revenue |
|----------|-----|---------|
| 2025-10-30 | 0.14 | 1.49 B$ |
| 2025-07-31 | 0.15 | 1.42 B$ |
| 2025-05-01 | 0.11 | 1.36 B$ |
| 2024-10-31 | 0.05 | 1.24 B$ |
| 2025-10-30 | 0.05 | 1.24 B$ |

**11. Financial Information**
**Revenue and Profitability:**
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $1.49B | 41.58% |
| 2025-06-30 | $1.42B | 41.80% |
| 2025-03-31 | $1.36B | 42.15% |
| 2024-12-31 | $1.29B | 42.42% |
| 2024-09-30 | $1.24B | 42.17% |

**Capital and Profitability:**
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $12.36B | 0.53% |
| 2025-06-30 | $11.53B | 0.59% |
| 2025-03-31 | $11.47B | 0.41% |
| 2024-12-31 | $10.77B | 0.53% |
| 2024-09-30 | $9.76B | 0.20% |

**Comprehensive Analysis**
The company's stock price has shown significant fluctuations in recent years, with a cumulative return of 106.94% as of the last day of data. The Alpha, Beta, and capital analysis indicates a strong performance in certain periods, but also significant declines in others. The RSI and PPO indicators show a low RSI value of 34.94 and a negative PPO value of -0.28, indicating a potential buying opportunity. The expected return is -4.00%, and the risk level is considered medium. Recent news articles indicate a boost in stock position and quarterly earnings previews, which may impact the company's stock price. Analyst opinions are generally positive, with a mean rating of 1.52 (~Buy) and a target price of 85.65 / 94.00 / 75.00.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.